The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, today announced the launch of its Lyophilized NGS ...
The global autogenous vaccines market is growing steadily, valued at around US$ 312.4 million in 2026 and projected to reach US$ 451.5 million by 2033, with a CAGR of 5.4% during the forecast period.